APEX1 and cancer: Furthermore, in human cancer cell lines, gossypol was more effective at killing cancer cells with APE1 overexpression than negative controls, and the combination of gossypol and cisplatin resulted in enhanced cell killing and higher antitumor activity in vivo than cisplatin alone.